Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Systems, methods, and related technologies are provided for generating interactive emails and tracking user interactions. In one implementation, an email can be received within an email client. The email can be rendered within the email client, such as by: presenting a first selectable element within the email client, presenting a second selectable element within the email client, and presenting one or more content items within the email client. A selection of the first selectable element can be received within the email client. In response to the selection of the first selectable element, a presentation of the one or more content items can be adjusted within the email client.

Abstract: Systems, methods, and related technologies are provided for generating interactive emails and tracking user interactions. In one implementation, an email can be received within an email client. The email can be rendered within the email client, such as by: presenting a first selectable element within the email client, presenting a second selectable element within the email client, and presenting one or more content items within the email client. A selection of the first selectable element can be received within the email client. In response to the selection of the first selectable element, a presentation of the one or more content items can be adjusted within the email client.

Abstract: Systems, methods, and related technologies are provided for generating interactive emails and tracking user interactions. In one implementation, an email an be received within an email client. The email can be rendered within the email client, such as by: presenting a first selectable element within the email client, presenting a second selectable element within the email client, and presenting one or more content items within the email client. A selection of the first selectable element can be received within the email client. In response to the selection of the first selectable element, a presentation of the one or more content items can be adjusted within the email client.

Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.

Abstract: Systems, methods, and related technologies are provided for generating interactive emails and tracking user interactions. In one implementation, an email an be received within an email client. The email can be rendered within the email client, such as by: presenting a first selectable element within the email client, presenting a second selectable element within the email client, and presenting one or more content items within the email client. A selection of the first selectable element can be received within the email client. In response to the selection of the first selectable element, a presentation of the one or more content items can be adjusted within the email client.

Abstract: Systems, methods, and related technologies are provided for generating interactive emails and tracking user interactions. In one implementation, an email can be received within an email client. The email can be rendered within the email client, such as by: presenting a first selectable element within the email client, presenting a second selectable element within the email client, and presenting one or more content items within the email client. A selection of the first selectable element can be received within the email client. In response to the selection of the first selectable element, a presentation of the one or more content items can be adjusted within the email client.

Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.

Abstract: Systems, methods, and related technologies are provided for generating interactive emails and tracking user interactions. In one implementation, an email can be received within an email client. The email can be rendered within the email client, such as by: presenting a first selectable element within the email client, presenting a second selectable element within the email client, and presenting one or more content items within the email client. A selection of the first selectable element can be received within the email client. In response to the selection of the first selectable element, a presentation of the one or more content items can be adjusted within the email client.

Abstract: One embodiment provides a method, comprising: receiving, from a client device, a request by a user to access an aggregate service device; authenticating, at an aggregate service device, the user to provide access to a plurality of cloud storage accounts of the user hosted by a single cloud storage service; providing, by the aggregate service device, data analogous to data of the plurality of cloud storage accounts; receiving, by the aggregate service device, a selection of data accessible by the user from the plurality of cloud storage accounts of the user; and facilitating data transfer associated with the selection.

Abstract: Embodiments described herein are directed to providing scalability to software applications. A computer system partitions a portion of data stored in a directory services system into multiple different data partitions. Each data partition includes a primary writable copy and at least one secondary read-only copy of the data. The computer system receives a client request for a portion of the data that is stored in the directory services system and accesses various stored partition mappings to determine which of the different data partitions includes the requested data. The computer system also accesses a dynamic copy locator to determine which of the read-only copies of the indicated partition to access and provide the accessed primary writeable copy of the indicated partition and the determined read-only copy to the client in a virtualized manner so that the client is not aware of the data partitions.

Abstract: Disclosed are novel peptides comprising SEQ ID NO: 1 and modifications thereof, which are effective in blocking leukocyte recruitment. The disclosed peptides are useful for treating diseases associated with leukocyte recruitment for example inhibiting metastasis of a solid tumor to the liver and lungs and for treating sepsis. Also disclosed are methods of screening for compounds having the ability to block leukocyte recruitment.

Abstract: One embodiment provides a method, comprising: receiving, from a client device, a request by a user to access an aggregate service device; authenticating, at an aggregate service device, the user to provide access to a plurality of cloud storage accounts of the user hosted by a single cloud storage service; providing, by the aggregate service device, data analogous to data of the plurality of cloud storage accounts; receiving, by the aggregate service device, a selection of data accessible by the user from the plurality of cloud storage accounts of the user; and facilitating data transfer associated with the selection.

Abstract: Embodiments described herein are directed to providing scalability to software applications. A computer system partitions a portion of data stored in a directory services system into multiple different data partitions. Each data partition includes a primary writable copy and at least one secondary read-only copy of the data. The computer system receives a client request for a portion of the data that is stored in the directory services system and accesses various stored partition mappings to determine which of the different data partitions includes the requested data. The computer system also accesses a dynamic copy locator to determine which of the read-only copies of the indicated partition to access and provide the accessed primary writeable copy of the indicated partition and the determined read-only copy to the client in a virtualized manner so that the client is not aware of the data partitions.

Abstract: A method of diagnosing and treating a human glioblastoma multiforme (GBM) brain tumor in a subject is disclosed. The method includes administering to the subject, an effective amount of composition having a peptide 12-20 amino acid residues in length and selected for its ability to bind preferentially to a subtype of human GBM cells identified as brain tumor initiating cells (BTICs) or highly invasive glioma cells (HIGCs).